Effectiveness of Arsenic Sulphuratum Rubrum in cases of Psoriasis

Role of Arsenicum Sulphuratum Rubrum in case of psoriasis: A single arm clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067934

Enrollment

Registered

2024-05-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L40-L45- Papulosquamous disorders

Interventions

Intervention1: Arsenicum Sulphuratum Rubrum: Effectiveness of Arsenicum Sulphuratum Rubrum in cases of psoriasis. Potency and dose will be selected basis of susceptibility of patient. Potency will be

Eligibility

Inclusion criteria

Inclusion criteria: .Self reported & pre-diagnosed cases of Psoriasis . .The symptoms of patient which will be comes under ICD 11 EA90.0 .Patients with symptomatology of Psoriasis. .Both sexes. .Patients willingly giving consent.

Exclusion criteria

Exclusion criteria: .Patients unwilling to take part or not giving consent to join the study. .Diagnosed cases of systemic diseases, psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. .Substance abuse and/ or dependence. .Suffering from other immune-compromised stage. .Undergoing homoeopathic treatment for any chronic disease within the last 6 months.

Design outcomes

Primary

Measure	Time frame
Assessment of improvement by using Simplified Psoriasis IndexTimepoint: 3 month	—

Secondary

Measure	Time frame
36-Item Short-Form Health Survey (SF-36).Timepoint: 3 month	—

Countries

India

Contacts

Public ContactPranjal Kumar

R.B.T.S. Govt. Homoeopathic Medical College and Hospital

sambitnayak123@gmail.com7854090438

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026